IF
ABBV icon

Insight Folios’s AbbVie ABBV Stock Holding History

Insight Folios’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.36M Buy
42,313
+1,941
+5% +$362K 2.98% 9
2024
Q2 		$6.92M Buy
40,372
+752
+2% +$125K 2.84% 10
2024
Q1 		$7.21M Sell
39,620
-8,661
-18% -$1.49M 2.92% 6
2023
Q4 		$7.48M Buy
48,281
+1,896
+4% +$276K 3.24% 3
2023
Q3 		$6.91M Sell
46,385
-5,111
-10% -$750K 3.38% 5
2023
Q2 		$6.94M Buy
51,496
+1,994
+4% +$292K 2.91% 10
2023
Q1 		$7.89M Buy
49,502
+594
+1% +$90.8K 3.5% 4
2022
Q4 		$7.9M Sell
48,908
-2,504
-5% -$384K 3.57% 3
2022
Q3 		$6.9M Buy
51,412
+1,058
+2% +$152K 3.51% 6
2022
Q2 		$7.71M Buy
50,354
+2,167
+4% +$331K 3.67% 2
2022
Q1 		$7.81M Buy
48,187
+1,036
+2% +$150K 3.48% 4
2021
Q4 		$6.38M Buy
47,151
+1,206
+3% +$142K 2.99% 3
2021
Q3 		$4.96M Buy
45,945
+2,144
+5% +$245K 2.73% 14
2021
Q2 		$4.93M Buy
43,801
+1,434
+3% +$162K 2.9% 14
2021
Q1 		$4.58M Buy
42,367
+531
+1% +$56.8K 3.14% 12
2020
Q4 		$4.48M Buy
41,836
+2,396
+6% +$230K 3.33% 9
2020
Q3 		$3.46M Buy
39,440
+1,407
+4% +$132K 3.2% 9
2020
Q2 		$3.73M Sell
38,033
-9,306
-20% -$819K 3.58% 1
2020
Q1 		$3.61M Buy
47,339
+4,353
+10% +$371K 4.13% 6
2019
Q4 		$3.81M Buy
+42,986
New +$3.57M 3.38% 11

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Insight Folios's ABBV Position: Q3 2024 in Review

Insight Folios increased its AbbVie (ABBV) stake by 4.8% in Q3 2024, buying an estimated $362K and bringing the position to 42,313 shares worth $8.36M. The position accounts for 2.98% of the portfolio, ranked #9.

Insight Folios first reported a position in ABBV in Q4 2019 and has held it in 20 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Insight Folios held 42,313 shares of AbbVie worth $8.36M as of Q3 2024.
  • Insight Folios bought 1,941 AbbVie shares in Q3 2024, an estimated $362K.
  • AbbVie made up 2.98% of Insight Folios's portfolio in Q3 2024, its #9 holding.
  • Insight Folios first reported a position in AbbVie in Q4 2019 and has held it in 20 quarters since.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Insight Folios's 13F filing for Q3 2024, filed 24 Oct 2024.